Vascular and metabolic dysfunction in Alzheimer's disease: a review. - Wikidata - awgldk - TriplyDB

Vascular and metabolic dysfunction in Alzheimer's disease: a review.

Vascular and metabolic dysfunction in Alzheimer's disease: a review.

http://www.wikidata.org/entity/Q34193337

about

Endocrine Risk Factors for Cognitive Impairment The Role of Sleep and Sleep Disorders in the Development, Diagnosis, and Management of Neurocognitive Disorders Integrative EEG biomarkers predict progression to Alzheimer's disease at the MCI stage Metabolite profiling of Alzheimer's disease cerebrospinal fluid Repair of oxidative DNA damage, cell-cycle regulation and neuronal death may influence the clinical manifestation of Alzheimer's disease.Model-based physiomarkers of cerebral hemodynamics in patients with mild cognitive impairment.DNA-PK and P38 MAPK: A Kinase Collusion in Alzheimer's Disease?Different Brain Regions are Infected with Fungi in Alzheimer's Disease.Transcranial near-infrared laser therapy applied to promote clinical recovery in acute and chronic neurodegenerative diseases.A viral vector expressing hypoxia-inducible factor 1 alpha inhibits hippocampal neuronal apoptosis A turning point for Alzheimer's disease?Current evidence for the clinical use of long-chain polyunsaturated n-3 fatty acids to prevent age-related cognitive decline and Alzheimer's disease.Insulin resistance predicts brain amyloid deposition in late middle-aged adults.Angiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink.Increased cerebral vascular reactivity in the tau expressing rTg4510 mouse: evidence against the role of tau pathology to impair vascular health in Alzheimer's disease Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: implications for early intervention and therapeutics.Flos Puerariae Extract Ameliorates Cognitive Impairment in Streptozotocin-Induced Diabetic Mice.Alzheimer's disease: a clinical practice-oriented review.Glycogen and amyloid-beta: key players in the shift from neuronal hyperactivity to hypoactivity observed in Alzheimer's disease?Compliance and Caregiver Satisfaction in Alzheimer's Disease: Results from the AXEPT Study.Metabolic syndrome and cognitive decline in early Alzheimer's disease and healthy older adults Diabetes-induced central neuritic dystrophy and cognitive deficits are associated with the formation of oligomeric reticulon-3 via oxidative stress.Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease.Comparison of Model-Based Indices of Cerebral Autoregulation and Vasomotor Reactivity Using Transcranial Doppler versus Near-Infrared Spectroscopy in Patients with Amnestic Mild Cognitive Impairment.Model-based quantification of cerebral hemodynamics as a physiomarker for Alzheimer's disease?Neuroendocrinology-based therapy for Alzheimer's disease.Proteolytic degradation of amyloid β-protein.Quintessential risk factors: their role in promoting cognitive dysfunction and Alzheimer's disease.Metabolomics: a novel approach to identify potential diagnostic biomarkers and pathogenesis in Alzheimer's disease.Cerebrovascular and mitochondrial abnormalities in Alzheimer's disease: a brief overview.Olfactory dysfunction: its early temporal relationship and neural correlates in the pathogenesis of Alzheimer's disease.Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.Inhibition of aminoacylase 3 protects rat brain cortex neuronal cells from the toxicity of 4-hydroxy-2-nonenal mercapturate and 4-hydroxy-2-nonenal.Genetic variation in MME in relation to neprilysin protein and enzyme activity, Aβ levels, and Alzheimer's disease risk.A Translational Systems Pharmacology Model for Aβ Kinetics in Mouse, Monkey, and Human.Glutathione prevents free fatty acids-induced oxidative stress and apoptosis in human brain vascular endothelial cells through Akt pathway.[Vascular factors in the pathogenesis of Alzheimer's disease].Changes in Blood Factors and Ultrasound Findings in Mild Cognitive Impairment and Dementia.Evaluation of Metabolic and Synaptic Dysfunction Hypotheses of Alzheimer's Disease (AD): A Meta-Analysis of CSF Markers.Dietary energy substrates reverse early neuronal hyperactivity in a mouse model of Alzheimer's disease.

P2860

Q26749493-7D2DFAB5-6A87-4E51-8CC6-97AF08347E50 Q26777958-F96A2B02-4726-48D2-A754-585904E78C77 Q27500371-632101A4-2F96-44C5-B72D-4D28964C2E7B Q28480903-2836F6C3-EBE1-435B-8A4C-89C4A8B36F55 Q33769079-3E96DC94-3460-48B7-8FE6-0EAB5D3157D3 Q33825909-340D7F9F-627A-4E92-9479-E1215EC98046 Q33892330-D15FF963-E996-486E-BB4C-6EFFA2B1697F Q34045152-B4601DA9-0071-4ED9-85A7-3733F1F562CA Q34092740-8C6960DC-C331-4161-BAC0-E88E0179E5D0 Q34095412-D712CB3B-9126-4885-B0DF-F7898A2F05D4 Q34197623-4D6FEB4A-2F43-418B-82BC-8093731F4D67 Q34330929-6BFDAAE3-0864-4F46-A2BB-10EEE38C5B3E Q34429975-1A05C7A7-BCE2-434E-9F2A-AF1A2CD62611 Q35023755-ADAAB1BB-0ED6-4393-83CD-0CF26EBBFE4C Q35143533-877B7FF9-344B-44C9-822F-604471DA2CE3 Q35256535-D3B4CFB1-3010-4D84-8FDB-23D4F92EF4E6 Q35594774-781979AE-791F-4044-8958-6375F6671606 Q35899503-9C7143F5-7557-4763-A88A-84ADFC03E64F Q35969643-D3AEFAB5-B48D-4791-B834-D0C6F3491F00 Q36383025-6E7DDEDF-EEE9-466E-8A8B-2A7CF4157C52 Q36880464-D703E3D2-40B1-404C-9747-FB32D1D98995 Q36890582-A53CF61C-ACC4-4E19-9F9F-F28174C873D2 Q36914722-140C2CAE-5CB3-44E9-9763-3BE7BF233B7A Q37589714-08C1CC23-BBAD-418A-975D-218A58953858 Q37712238-758C2B70-938F-4A24-AAAF-1E27839905D7 Q37995980-E7857D93-6BBC-4FBE-8943-D05EA1F73EBB Q38016899-1730926F-C5B0-4EB9-9579-F63EC4E073A4 Q38034108-066241BA-7DE1-4C40-B150-3BEC99FA3C58 Q38051186-30D8CD20-AFEB-4989-ACB3-7F2B5D44EAB6 Q38327281-9FB6EE8C-07FC-465C-9F97-D1234A0111CB Q38461098-88920E17-553B-4276-B594-6DADA7946178 Q38879090-90F1E2AA-340B-452E-B089-8BAB08E3A052 Q41553884-08CFA3B5-8384-4FA4-BA6D-7A35D749F0E0 Q42561537-B45536DF-14AB-43D0-A210-2B920DC8C6C9 Q42621620-98CCFFBD-0E53-472F-9396-6444E31E8922 Q45375833-7AB71E09-E3D7-4238-9E39-DAFFEE77439E Q45955749-C2D5F42E-0DE5-43EE-ABA2-0310FD9C134D Q47170195-ADC19560-7A60-456C-8277-49A6416B90B3 Q47937645-8F41CAC8-6053-4677-A46D-EE701909E4E0 Q48253009-AE92C7AE-86CE-4B48-9982-B4BC996341D5

P2860

Vascular and metabolic dysfunction in Alzheimer's disease: a review.

http://www.wikidata.org/entity/Q34193337

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Vascular and metabolic dysfunction in Alzheimer's disease: a review.

@ast

Vascular and metabolic dysfunction in Alzheimer's disease: a review.

@en

Vascular and metabolic dysfunction in Alzheimer's disease: a review.

@nl

type

label

Vascular and metabolic dysfunction in Alzheimer's disease: a review.

@ast

Vascular and metabolic dysfunction in Alzheimer's disease: a review.

@en

Vascular and metabolic dysfunction in Alzheimer's disease: a review.

@nl

prefLabel

Vascular and metabolic dysfunction in Alzheimer's disease: a review.

@ast

Vascular and metabolic dysfunction in Alzheimer's disease: a review.

@en

Vascular and metabolic dysfunction in Alzheimer's disease: a review.

@nl

P1433

Q34193337-940C523B-417C-48DC-9BE1-9C4C8317E618

P1476

Q34193337-C465B3CA-2235-4FB1-990A-AAFF3BB55AF3

P2093

Q34193337-2ACFD80A-9D8B-40BE-8C1F-E10D2C73BA5A

Q34193337-38D7B6C8-68E7-494E-B2FF-8CD7A59191DB

Q34193337-9D237444-0258-4612-A479-34197CA52C1F

Q34193337-BE698327-A874-445A-859F-641B222F0CAC

P2860

Q34193337-0230CA1A-F6CD-496F-AE55-BE004335A32E

Q34193337-03E3834B-70CE-4CBB-A035-199B26DE6976

Q34193337-059FCC41-F294-4D0E-A740-A7D15C03FE21

Q34193337-06E370A7-7638-4F7F-9D1A-6EAE3F6665C4

Q34193337-079EBB82-42E4-4744-90FD-C4C44B62459E

Q34193337-07B4CFF9-AF67-4147-9043-3E0C34B9E44D

Q34193337-0851ED69-C68F-43F5-A7A4-0C48458866E1

Q34193337-08FB8BBC-3088-41FB-9BC5-F99E22E7480C

Q34193337-0A55F343-3D91-4C5D-A5F7-1564533ABC19

Q34193337-0AD77566-ACEA-49FC-A8A7-0B6B5F987789

P304

Q34193337-163CF3F5-7A6B-44E5-9ADB-7DBF563BA0FA

P31

Q34193337-3865A361-776A-4A93-A2BB-7F08EFB887F1

P356

Q34193337-170DA26D-E10C-4341-9C74-0CAD285AB611

P433

Q34193337-3EDC2EFA-A44E-4FBC-846B-6D758A97570D

P478

Q34193337-A281E860-5099-47F5-A358-A89C95E56CD2

P577

Q34193337-FA29E7B1-B784-43A8-9820-5A48D4818495

P5875

Q34193337-0DADF062-3CB3-4DEA-8DA0-D680D3CC6D4E

P698

Q34193337-A4BA4351-FC7D-4DCC-B2B0-042465AF52BD

P921

Q34193337-00353650-213A-412D-8FBC-7398A9CB3ECE

P356

EBM.2011.010355

P1433

Experimental Biology and Medicine

P1476

Vascular and metabolic dysfunction in Alzheimer's disease: a review.

@en

P2093

Farida Sohrabji

http://www.w3.org/2001/XMLSchema#string

Ian V J Murray

http://www.w3.org/2001/XMLSchema#string

John M Lawler

http://www.w3.org/2001/XMLSchema#string

Joseph F Proza

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases

Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis

Threats to the mind: aging, amyloid, and hypertension

Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease

Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease

Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b

The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology

Alzheimer's disease: the cholesterol connection

Changes in brain glucose metabolism as a key to the pathogenesis of Alzheimer's disease

Common mechanisms of amyloid oligomer pathogenesis in degenerative disease

P304

772-782

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1258/EBM.2011.010355

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

236

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51226340

http://www.w3.org/2001/XMLSchema#string

P698

21680755

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease